Jaguar Health (JAGX)
NasdaqMarket Closed
Last updated
- Market Cap
- $3,100,980
- P/E
- —
- P/FCF
- —
- P/S
- 0.11
- Enterprise Value
- $14,871,980
- Sector
- —
- Industry
- —
- Address
- 200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Jaguar Health Plans To Adopt AI Platform For Crofelemer In Treating Intestinal Failure
Jaguar Health Completes Private Placement Deal
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- $3,100,980
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- $14,871,980
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.47
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.11
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -0.64
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.53
- EPS
- -10.14
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -$6,726,000
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -792.44%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -153.3%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 2.35
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0.69
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.4
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.15
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- $249,255
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 0.6
Income Statement
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Revenue | 1.23M | 20.27M | 3.24M | 3.08M | 2.98M |
| Cost of revenue | 1.03M | 1.16M | 2.2M | 532K | 527K |
| Gross profit | 194K | 19.11M | 1.04M | 2.55M | 2.45M |
| Operating income | -7.6M | 10.18M | -20.44M | -7.24M | -8.01M |
| EBITDA | -7.12M | 10.66M | -19.97M | -6.76M | -7.53M |
| Net income | -12.7M | -7.02M | -23.2M | -9.5M | -10.41M |
| Income taxes | 0 | 0 | 0 | 0 | 0 |
| Interest expense | -161K | -699K | -132K | -6K | 15K |
| Other operating expenses | 0 | 0 | 0 | 0 | 0 |
| Total operating expenses | 7.79M | 8.93M | 21.48M | 9.79M | 10.46M |
| Basic EPS | -15.7 | -13.6 | -104.52 | -181.65 | -358.94 |
| Diluted EPS | -15.7 | -13.6 | -104.52 | -181.65 | -358.94 |
Balance Sheet
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Total assets | 34.19M | 37.43M | 38.32M | 49.47M | 48.27M |
| Total liabilities | 29.27M | 53.19M | 57.01M | 45.11M | 41.39M |
| Total equity | 4.92M | -15.75M | -18.69M | 4.36M | 6.88M |
| Cash & equivalents | 3.79M | 7.28M | 968K | 3.53M | 2.21M |
| Current assets | 17.53M | 20.21M | 20.35M | 29.4M | 27.9M |
| Current liabilities | 25.38M | 40.69M | 40.65M | 36.12M | 29.22M |
| Accounts payable | 4.79M | 4.96M | 8.69M | 8.44M | 6.62M |
| Receivables | 198K | 280K | 1.7M | 1.5M | 1.32M |
| Inventories | 7.32M | 7.82M | 8.6M | 10.63M | 10.72M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long-term debt | 1.73M | 11.08M | 15.08M | 7.65M | 10.74M |
Cash Flow
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Operating cash flow | -5.34M | 8.83M | -5.49M | -4.69M | -6.2M |
| Investing cash flow | 0 | 0 | 13K | -54K | 0 |
| Financing cash flow | 1.86M | -6.62M | 9.79M | 6.26M | 2.66M |
| Change in cash | -3.47M | 2.23M | 4.31M | 1.32M | -3.48M |
| Net income | -12.8M | 8.27M | -23.19M | -9.78M | -10.58M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 424B5 — Jaguar Health, Inc. | View Filing | |
| edgar index | 424B3 — Jaguar Health, Inc. | View Filing | |
| edgar index | 10-Q — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | NT 10-Q — Jaguar Health, Inc. | View Filing | |
| edgar index | EFFECT — Jaguar Health, Inc. | View Filing | |
| edgar index | POS AM — Jaguar Health, Inc. | View Filing | |
| edgar index | DEF 14A — Jaguar Health, Inc. | View Filing | |
| edgar index | 424B3 — Jaguar Health, Inc. | View Filing | |
| edgar index | 424B3 — Jaguar Health, Inc. | View Filing | |
| edgar index | S-1/A — Jaguar Health, Inc. | View Filing | |
| edgar index | PRE 14A — Jaguar Health, Inc. | View Filing | |
| edgar index | EFFECT — Jaguar Health, Inc. | View Filing | |
| edgar index | EFFECT — Jaguar Health, Inc. | View Filing | |
| edgar index | S-1 — Jaguar Health, Inc. | View Filing | |
| edgar index | S-1 — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | D — Jaguar Health, Inc. | View Filing | |
| edgar index | D — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K/A — Jaguar Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEFA14A — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | 10-Q — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | NT 10-Q — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | DEFA14A — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | DEF 14A — Jaguar Health, Inc. | View Filing | |
| edgar index | ARS — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | PRE 14A — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | 10-K — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | S-8 — Jaguar Health, Inc. | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | NT 10-K — Jaguar Health, Inc. | View Filing | |
| edgar index | DEF 14A — Jaguar Health, Inc. | View Filing | |
| edgar index | PRE 14A — Jaguar Health, Inc. | View Filing | |
| edgar index | 4 — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing | |
| edgar index | 4 — Jaguar Health, Inc. | View Filing | |
| edgar index | 4 — Jaguar Health, Inc. | View Filing | |
| edgar index | 4 — Jaguar Health, Inc. | View Filing | |
| edgar index | 8-K — Jaguar Health, Inc. | View Filing |